Enhancing anti-gastrointestinal cancer activities of CLDN18.2 CAR-T armored with novel synthetic NKG2D receptors Containing DAP10 and DAP12 signaling domains. https://www.biorxiv.org/content/10.1101/2023.05.17.541124v1?med=mas
Enhancing anti-gastrointestinal cancer activities of CLDN18.2 CAR-T armored with novel synthetic NKG2D receptors Containing DAP10 and DAP12 signaling domains. https://www.biorxiv.org/content/10.1101/2023.05.17.541124v1?med=mas